Alexander Lauten

Showing 1-8 of 8 articles

Author Henryk Dreger

Interventions for valvular disease

Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

Dreger H, Mattig I, Hewing B, Knebel F, Lauten A, Lembcke A, Thoenes M, Roehle R, Stangl V, Landmesser U, Grubitzsch H, Stangl K, Laule M, Schöbel C, Baumann G

January 14, 2020 | 10.4244/EIJ-D-19-00901

Author Christina Paitazoglou

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou C, Özdemir R, Pfister R, Bergmann M, Bartunek J, Kilic T, Lauten A, Schmeisser A, Zoghi M, Anker S, Sievert H, Mahfoud F

August 29, 2019 | 10.4244/EIJ-D-19-00342

Author Alexander Bufe

The Experts “Live” Workshop of the EuroCTO Club 2017, Berlin

Bufe A, Di Mario C, Landmesser U, Gessner M, Sianos G, Garbo R, Dini C, Lauer B, Boudou N, Grancini L, Avran A, Lauten A, Mashayekhi K, Hildick-Smith D, Escaned J, Buettner H, Reifart N, Lapp H, Galassi A, Werner G

April 20, 2018 | 10.4244/EIJV13I17A324

Author Daniel Kretzschmar

Interventions for heart failure

PERKAT RV: first in vivo data of a novel right heart assist device

Kretzschmar D, Lauten A, Schubert H, Bischoff S, Schulze PC, Ferrari M

April 6, 2018 | 10.4244/EIJ-D-17-00899

Author Felix Katte

Interventions for valvular disease

Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis

Katte F, Franz M, Jung C, Figulla H, Leistner D, Jakob P, Stahli B, Kretzschmar D, Lauten A, Figulla H

February 20, 2018 | 10.4244/EIJ-D-17-00476

Author Hans R. Figulla

Interventions for valvular disease

Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve

Figulla H, Kiss K, Lauten A

September 18, 2016 | 10.4244/EIJV12SYA32

Author Alexander Lauten

Interventions for valvular disease

Tricuspid valve interventions in 2015

Lauten A, Figulla HR

September 17, 2015 | 10.4244/EIJV11SWA37

Author Alexander Lauten

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

1

Latest news

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

January 17, 2020

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

January 14, 2020

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke